| 摘要 |
The invention relates to compounds of formula (I), wherein R1, R2 and A have the meanings given in claim 1, are potent 5HT2A antagonists and are suitable for treating psychoses, schizophrenia, depression, neurological disorders, impaired memory, Parkinsons disease, amyotrophic lateral sclerosis, Alzheimers disease, Huntingtons disease, eating disorders such as bulimia and anorexia nervosa, PreMenstrual Syndrome andor for positively influencing obsessivecompulsive disorders, (OCD). |
